Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions

about

Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs.

P2860

Q38638116-0264DA9B-7F5F-4714-B94C-360D3192ABEF

P2860

Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions

Item

http://www.wikidata.org/entity/Q38687534

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Integrated care of muscular dy ...... d rehabilitative interventions

@en

type

Item

label

Integrated care of muscular dy ...... d rehabilitative interventions

@en

prefLabel

Integrated care of muscular dy ...... d rehabilitative interventions

@en

P1476

Integrated care of muscular dy ...... d rehabilitative interventions

@en

P2093

Adele D'Amico

http://www.w3.org/2001/XMLSchema#string

Alessandra Gaiani

http://www.w3.org/2001/XMLSchema#string

Alessandra Sagliocchi

http://www.w3.org/2001/XMLSchema#string

Antonella Zaccaro

http://www.w3.org/2001/XMLSchema#string

Claudio Semplicini

http://www.w3.org/2001/XMLSchema#string

Erika Brighina

http://www.w3.org/2001/XMLSchema#string

Federica Civati

http://www.w3.org/2001/XMLSchema#string

Gianluca Vita

http://www.w3.org/2001/XMLSchema#string

Giulia Colia

http://www.w3.org/2001/XMLSchema#string

Giulia Ricci

http://www.w3.org/2001/XMLSchema#string

P2860

Drug treatment of Duchenne muscular dystrophy: available evidence and perspectives

The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing an

Molecular basis of muscular dystrophies.

Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.

Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy.

A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.

The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy.

Burden, professional support, and social network in families of children and young adults with muscular dystrophies.

"I have got something positive out of this situation": psychological benefits of caregiving in relatives of young people with muscular dystrophy.

P304

19-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Corrado Angelini

Luca Bello

Angela Berardinelli

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28690390

http://www.w3.org/2001/XMLSchema#string

P921

An Eadailt

P932

5479104

http://www.w3.org/2001/XMLSchema#string

Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions

about

P2860

P2860

Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P921

P932